ALPCO to Exhibit with BÜHLMANN Laboratories at DDW 2013 and Feature Fecal Calprotectin ELISA
The partnering companies will feature BÜHLMANN's Fecal Calprotectin ELISA that is pending FDA clearance for IVD use in the United States. - May 16, 2013
ALPCO Adds FDA Registered Renin RIA from Cisbio to Product Offering
ALPCO now offering a line of RIA products from Cisbio in the United States. - May 07, 2013
ALPCO Launches Human Osteopontin ELISA
ALPCO launches the first assay in a new line of species-specific Osteopontin ELISAs. - May 01, 2013
ALPCO Expands Product Offering with EuroFlow™ Flow Cytometry Reagents and Infinicyt™ Analytical Software from Cytognos S.L.
Starting April 30, 2013 ALPCO will begin offering flow cytometry solutions from Cytognos S.L. - April 30, 2013
ALPCO Launches Their First STELLUX Chemiluminescent ELISA
ALPCO announces the launch of their STELLUX Rodent Insulin ELISA, the first ELISA launched in their new STELLUX Chemiluminescent assay product line. - April 26, 2013
ALPCO Expands Product Offering with Addition of Flow Cytometry Reagents
After over twenty years of providing immunoassay kits worldwide, ALPCO has added flow cyometry reagents to their product offering. - March 25, 2013
General Biologicals Corporation Signs ALPCO as a Distributor in North America
ALPCO will distribute Infectious Disease assays from GBC in North America. - December 18, 2012
ALPCO Diagnostics Recognized in Support of American Red Cross’ Hurricane Sandy Relief Efforts
ALPCO presented with plaque of recognition for their contribution to the American Red Cross' Hurricane Sandy Relief Fund. - December 12, 2012
ALPCO Diagnostics and BioCat GmbH Sign Exclusive Distribution Agreement at MEDICA 2012
Beginning January 1, 2013, BioCat GmbH will be ALPCO's exclusive distributor in Germany. - December 10, 2012
ALPCO Diagnostics and Euro Diagnostica Announce Distribution Agreement
ALPCO to distribute Euro Diagnostica products in North America. - December 07, 2012
ALPCO’s Mouse Sclerostin ELISA to be Featured at ASBMR
A collaboration between ALPCO Diagnostics and the Mayo Clinic has yielded a poster that will be presented at this year’s ASBMR meeting in Minneapolis, MN. - October 04, 2012
ALPCO Adds an FDA Registered ELISA for West Nile Virus
ALPCO announces the addition of two FDA Registered ELISAs for the measurement of West Nile Virus. - September 05, 2012
ALPCO Diagnostics Launches Mouse Sclerostin ELISA
ALPCO Diagnostics announces the launch of an ELISA specific for measuring mouse sclerostin in serum and plasma. - July 10, 2012
ALPCO & Argutus Medical Collaboration
Kidney & Liver Toxicity Gold Standard Rat Alpha GST ELISA Available Once Again - June 26, 2012
ALPCO Diagnostics Recognized for Support of the American Red Cross 2011 Relief Efforts
ALPCO was recognized on May 29, 2012 for their generous contributions to the American Red Cross in 2011. - June 11, 2012
Detroit R&D and ALPCO Diagnostics Sign Distribution Agreement
ALPCO Diagnostics and Detroit R&D agree to a distribution partnership in North America. - March 20, 2012
Biomedica Immunoassays Appoints ALPCO Diagnostics as Its Exclusive Distributor in Canada
ALPCO Diagnostics was recently appointed as Biomedica Immunoassays' exclusive distributor in Canada. - February 15, 2012
WILEX Inc. and ALPCO Diagnostics Sign Marketing and Distribution Agreement for North America
WILEX AG announces that its wholly owned US subsidiary WILEX Inc., Cambridge, MA, USA, entered into a exclusive co-marketing and distribution agreement with American Laboratory Products Company Inc., (ALPCO Diagnostics) Salem, NH, USA, for the commercialization of the Serum HER-2/neu ELISA test in North America. - October 10, 2011
ALPCO Appoints CST China as Their Exclusive Distributor in China
ALPCO Diagnostics, a leading manufacturer and distributor of high quality immunoassay kits, is pleased to announce that they have appointed CST (Shanghai) Biological Reagents Company Ltd. (CST China) as their new distributor in China. With CST China as their new distribution channel in China,... - June 23, 2011
ALPCO Diagnostics' Partnership with Electra-Box Diagnostica AB Looks to the Future of American-Swedish Research Collaborations
It is a long-standing tradition in the scientific research community for researchers to engage in collaborative studies spanning international borders. In keeping with this spirit, and with a desire to foster international collaboration, ALPCO Diagnostics is pleased to announce that they have entered into a distribution agreement with Electra-Box Diagnostica AB of Sweden. - May 13, 2011
ALPCO Appoints Cosmo Bio Co., Ltd. as Their New Distribution Channel in Japan
Cosmo Bio Co., Ltd. is a distributor of high quality research reagents and instruments throughout Japan. ALPCO Diagnostics is a leading developer and distributor of high quality immunoassay kits in the US. The two companies feel that their mutual commitment to offering quality products in the life science research area will be the basis for a strong partnership. - January 10, 2011
Interest in Sclerostin as a Regulator of Bone Formation Remains High
Sclerostin, a protein produced primarily in osteocytes, inhibits osteoblast activity via antagonism of the wnt signaling pathway and, as such, has garnered a great deal of attention as a potential therapeutic target for increasing bone formation. The annual publication rate for peer-reviewed... - December 07, 2010
ALPCO Diagnostics Launches First Commercially Available Sclerostin ELISA in the U.S.
ALPCO Diagnostics recently launched an ELISA specific for measuring human sclerostin in serum and plasma. Sclerostin inhibits osteoblast activity via antagonism of the wnt signaling pathway and plays a key role in the regulation of bone formation. Reports show that sclerostin expression and/or... - July 27, 2010
ALPCO Diagnostics Exclusively Offers Animal NGAL Assays from BioPorto
BioPorto Diagnostics has awarded ALPCO Diagnostics exclusive distributorship for its animal NGAL ELISAs to the North American market. BioPorto’s prominence is unrivaled in immunoassays for measuring NGAL (neutrophil gelatinase associated lipocalin) – the breakthrough kidney injury... - June 17, 2010
ALPCO Diagnostics Prepares for Launch of Unique Immunoassays
ALPCO Diagnostics announces the recent hiring of Leon F. Hebert Jr., Ph.D. As ALPCO’s new Diabetes and Obesity Product Manager, Dr. Hebert will be charged with overseeing the launch of several new ELISA research tools, including: Mouse Proinsulin ELISA, Rat Proinsulin ELISA, Mouse C-peptide... - June 09, 2010
U.S. Patent Granted for the Multimeric Adiponectin ELISA
A United States patent has been granted to Sekisui Medical Corp. (Tokyo, Japan), the inventors of the Multimeric Adiponectin ELISA. The Multimeric Adiponectin ELISA is distributed in the U.S. and Canada exclusively by ALPCO Diagnostics. - March 23, 2010
ALPCO Launches Rat and Mouse Proinsulin ELISA Kits
ALPCO Immunoassays has developed two new low-sample volume ELISAs for the quantitative analysis of total proinsulin (I and II) in rats and mice. - January 26, 2010
ALPCO Diagnostics and BioPorto Diagnostics Enter Into Distribution Partnership
ALPCO Diagnostics has taken on the responsibility to promote and sell BioPorto Diagnostics’ immunoassays on the US and Canadian markets. The primary product focus is BioPorto’s unrivalled portfolio of human and animal immunoassays for measuring NGAL – the breakthrough kidney... - December 08, 2009
News at MEDICA: ALPCO Announces the Launch of Several New Products in 2009
ALPCO will return to MEDICA, showcasing these new immunoassay kits, which cement the company's perennial committment to serving the demands of the pre-clinical research market. This will be ALPCO's fourth year at MEDICA as part of the “Best of New England” consortium of companies, located in the US pavilion in Halle 3, D15-4. - November 16, 2009
ALPCO Introduces Immundiagnostik Bone Sialoprotein (BSP) ELISA to North America
ALPCO Diagnostics introduces Immundiagnostik's Bone Sialoprotein ELISA to North America. The BSP ELISA exhibits outstanding sensitivity and specificity for the underglycosylated or carbohydrate deficient Bone Sialoprotein. - October 15, 2009
ALPCO and Athera Biotechnologies Sign Distribution Agreement in North America
ALPCO Diagnostics, a leading developer and distributor of high quality immunoassay kits, is pleased to announce that they have signed with Athera Biotechnologies as their new distribution channel in the North America. Sean Conley, COO of ALPCO, said “We are very excited about the... - October 06, 2009
ALPCO Launches GLP-1 (Active 7-36) and (7-36 and 9-36) ELISA kits
ALPCO Immunoassays is pleased to introduce two new ELISA kits for research use for measurement of the active (7-36) and combined (7-36 and 9-36) GLP-1 fragments. - September 23, 2009
ALPCO Appoints Stratech Scientific as Their New Distribution Channel in the UK
Stratech Scientific is a distributor of high quality products for research laboratories throughout the UK and Europe. ALPCO Diagnostics is a leading developer and distributor of high quality immunoassay kits in the US. The two companies feel that their mutual commitment to offering quality products in the life science research area will be the basis for a strong partnership. - August 13, 2009
ALPCO Launches Mouse HMW and Total Adiponectin ELISA
ALPCO Diagnostics has introduced a Mouse HMW Adiponectin ELISA kit that facilitates the testing process for this biomarker. - August 07, 2009
Announcing the Launch of the New 25-OH Vitamin D ELISA: Exceptional Correlation to LC-MS/MS in a User-Friendly, Automatable ELISA Format
Serum measurements of 25-OH vitamin D by ELISA are easy and cost-effective for research laboratories who do not have access to the gold standard method, LC-MS/MS with the new 25-OH vitamin D ELISA kit offered by ALPCO. - February 27, 2009